Jeffry Adiwidjaja

9PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsCell physiologyEmergency medicineNutritional epidemiologyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 07, 2023
Application of physiologically based pharmacokinetic modeling to understand real-world outcomes in patients receiving imatinib for chronic myeloid leukemia.

Josephine A Adattini, Jeffry Adiwidjaja, Annette S Gross

|Apr 23, 2022
Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS-CoV-2 Infection: A Case Study With Imatinib.

Jeffry Adiwidjaja, Josephine A Adattini, Alan V Boddy

|Apr 16, 2022
Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH).

William A Murphy, Jeffry Adiwidjaja, Noora Sjöstedt

|Jan 20, 2022
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib.

Jeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan

|Sep 18, 2021
Physiologically-based pharmacokinetic model predictions of inter-ethnic differences in imatinib pharmacokinetics and dosing regimens.

Jeffry Adiwidjaja, Annette S Gross, Alan V Boddy

Pageof 2